Evidence map›Paper›PMID 34812845›Full record

ArticleJAMA network open2021

Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.

Kate Zinszer, Britt McKinnon, Noémie Bourque, Laura Pierce, Adrien Saucier, Alexandra Otis, Islem Cheriet, Jesse Papenburg, Marie-Ève Hamelin, Katia Charland and 13 more

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 1 country.

Kate ZinszerUniversity of Montreal, Montreal, Quebec, Canada.
Britt McKinnonUniversity of Montreal, Montreal, Quebec, Canada.
Noémie BourqueUniversity of Montreal, Montreal, Quebec, Canada.
Laura PierceCentre for Public Health Research, Montreal, Quebec, Canada.
Adrien SaucierUniversity of Montreal, Montreal, Quebec, Canada.
Alexandra OtisCentre for Public Health Research, Montreal, Quebec, Canada.
Islem CherietUniversity of Montreal, Montreal, Quebec, Canada.
Jesse PapenburgMontreal Children's Hospital, Montreal, Quebec, Canada.
Marie-Ève HamelinResearch Centre Laval University, Quebec City, Quebec, Canada.
Katia CharlandCentre for Public Health Research, Montreal, Quebec, Canada.
Julie CarbonneauResearch Centre Laval University, Quebec City, Quebec, Canada.
Monica ZahreddineCentre for Public Health Research, Montreal, Quebec, Canada.
Ashley SavardCentre for Public Health Research, Montreal, Quebec, Canada.
Geneviève FortinUniversity of Montreal, Montreal, Quebec, Canada.
Alexander ApostolatosUniversity of Montreal, Montreal, Quebec, Canada.
Nancy HaleyDirection régionale de la santé publique du Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal, Montreal, Quebec, Canada.
Nathalie RattéDirection régionale de la santé publique du Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal, Montreal, Quebec, Canada.
Isabel LaurinUniversity of Montreal, Montreal, Quebec, Canada.
Cat Tuong NguyenDirection régionale de la santé publique du Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal, Montreal, Quebec, Canada.
Patrica ConrodUniversity of Montreal, Montreal, Quebec, Canada.
Guy BoivinResearch Centre Laval University, Quebec City, Quebec, Canada.
Gaston De SerresNational Institute of Public Health of Quebec, Quebec City, Quebec, Canada.
Caroline QuachUniversity of Montreal, Montreal, Quebec, Canada.
Université de Montréal · CACentre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal · CAUniversité Laval · CACentre Hospitalier Universitaire Sainte-Justine · CAInstitut National de Santé Publique du Québec · CAMontreal Children's Hospital · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Quebec prioritized in-person learning after the first wave of the COVID-19 pandemic, with school closures being implemented temporarily in selected schools or in hot-spot areas. Quebec's decision to keep most schools open was controversial, especially in Montreal, which was the epicenter of Canada's first and second waves; therefore, understanding the extent to which children were infected with SARS-CoV-2 provides important information for decisions about school closures. Objective: To estimate the seroprevalence of SARS-CoV-2 antibodies in children and teenagers in 4 neighborhoods of Montreal, Canada. Design, Setting, and Participants: This cohort study (the Enfants et COVID-19: Étude de séroprévalence [EnCORE] study) enrolled a convenience sample of children aged 2 to 17 years between October 22, 2020, and March 22, 2021, in Montreal, Canada. Exposures: Potential exposure to SARS-CoV-2. Main Outcomes and Measures: The main outcome was seroprevalence of SARS-CoV-2 antibodies, collected using dried blood spots (DBSs) and analyzed with a research-based enzyme-linked immunosorbent assay (ELISA). Parents also completed an online questionnaire that included questions on self-reported COVID-19 symptoms and tests, along with sociodemographic questions. Results: This study included 1632 participants who provided a DBS sample from 30 day cares, 22 primary schools, and 11 secondary schools. The mean (SD) age of the children who provided a DBS sample was 9.0 (4.4) years; 801 (49%) were female individuals, with 354 participants (22%) from day cares, 725 (44%) from primary schools, and 553 (34%) from secondary schools. Most parents had at least a bachelor's degree (1228 [75%]), and 210 (13%) self-identified as being a racial or ethnic minority. The mean seroprevalence was 5.8% (95% CI, 4.6%-7.0%) but increased over time from 3.2% (95% CI, 0.7%-5.8%) in October to November 2020 to 8.4% (95% CI, 4.4%-12.4%) in March to April 2021. Of the 95 children with positive SARS-CoV-2 antibody results, 78 (82%) were not tested or tested negative with reverse transcription-polymerase chain reaction (RT-PCR) testing, and all experienced mild (49 [52%]) or no clinical symptoms (46 [48%]). The children of parents who self-identified as belonging to a racial and ethnic minority group were more likely to be seropositive compared with children of White parents (adjusted seroprevalence ratio, 1.9; 95% CI, 1.1-2.6). Conclusions and Relevance: These results provide a benchmark of the seroprevalence status in Canadian children. The findings suggest that there was more transmission occurring in children compared with what was being detected by RT-PCR, although children experienced few or mild symptoms. It will be important to continue monitoring the serological status of children, particularly in the context of new COVID-19 variants of concern and in the absence of mass vaccination campaigns targeting young children.

Indexed as

AdolescentAntibodies, ViralChildChild, PreschoolCOVID-19COVID-19 Serological TestingCross-Sectional StudiesEthnicityFemaleHumansMalePrevalenceQuebecSARS-CoV-2Seroepidemiologic StudiesAntibodies, Viral

Identifiers

PMID34812845
PMCPMC8611475
OpenAlexW3215321803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.